Point72 Asset Management’s Heron Therapeutics HRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-4,775,877
| Closed | -$10.5M | – | 1549 |
|
2025
Q1 | $10.5M | Buy |
4,775,877
+1,700,068
| +55% | +$3.74M | 0.02% | 523 |
|
2024
Q4 | $4.71M | Buy |
+3,075,809
| New | +$4.71M | 0.01% | 682 |
|
2024
Q2 | – | Sell |
-5,600
| Closed | -$15.5K | – | 1438 |
|
2024
Q1 | $15.5K | Buy |
+5,600
| New | +$15.5K | ﹤0.01% | 1377 |
|
2023
Q3 | – | Sell |
-22
| Closed | -$26 | – | 1939 |
|
2023
Q2 | $26 | Sell |
22
-34,012
| -100% | -$40.2K | ﹤0.01% | 1554 |
|
2023
Q1 | $51.4K | Buy |
+34,034
| New | +$51.4K | ﹤0.01% | 1265 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 1234 |
|
2021
Q4 | – | Sell |
-1,600,486
| Closed | -$17.1M | – | 1117 |
|
2021
Q3 | $17.1M | Buy |
1,600,486
+1,357,037
| +557% | +$14.5M | 0.08% | 330 |
|
2021
Q2 | $3.78M | Buy |
243,449
+178,449
| +275% | +$2.77M | 0.02% | 610 |
|
2021
Q1 | $1.05M | Sell |
65,000
-45,382
| -41% | -$736K | ﹤0.01% | 744 |
|
2020
Q4 | $2.34M | Sell |
110,382
-150,959
| -58% | -$3.19M | 0.01% | 667 |
|
2020
Q3 | $3.87M | Buy |
+261,341
| New | +$3.87M | 0.02% | 571 |
|
2019
Q2 | – | Sell |
-173,700
| Closed | -$4.25M | – | 1314 |
|
2019
Q1 | $4.25M | Buy |
+173,700
| New | +$4.25M | 0.02% | 509 |
|
2018
Q3 | – | Sell |
-20,000
| Closed | -$777K | – | 927 |
|
2018
Q2 | $777K | Buy |
+20,000
| New | +$777K | ﹤0.01% | 690 |
|
2017
Q2 | – | Sell |
-133,483
| Closed | -$2M | – | 786 |
|
2017
Q1 | $2M | Buy |
+133,483
| New | +$2M | 0.01% | 598 |
|
2015
Q4 | – | Sell |
-1,100
| Closed | -$27K | – | 692 |
|
2015
Q3 | $27K | Sell |
1,100
-250,400
| -100% | -$6.15M | ﹤0.01% | 667 |
|
2015
Q2 | $7.84M | Sell |
251,500
-248,500
| -50% | -$7.74M | 0.05% | 346 |
|
2015
Q1 | $7.28M | Sell |
500,000
-10,100
| -2% | -$147K | 0.05% | 359 |
|
2014
Q4 | $5.13M | Buy |
+510,100
| New | +$5.13M | 0.04% | 402 |
|